Immediate Treatment for Anaphylaxis
Intramuscular epinephrine is the only first-line treatment for anaphylaxis and must be administered immediately—all other interventions are secondary and should never delay epinephrine. 1, 2
Primary Intervention: Epinephrine Administration
Administer intramuscular epinephrine 0.01 mg/kg (1:1000 concentration) into the vastus lateralis (anterolateral thigh) immediately upon recognition of anaphylaxis. 1, 3
Dosing specifics:
- Adults and children >50 kg: 0.5 mg maximum single dose 1
- Children 25-50 kg: 0.3 mg (or 0.3 mg autoinjector) 1
- Children 10-25 kg: 0.15 mg (or 0.15 mg autoinjector) 1
- Repeat every 5-15 minutes if symptoms persist or progress 1
Critical administration details:
- The lateral thigh (vastus lateralis) is the mandatory injection site because intramuscular administration in the thigh achieves higher peak plasma concentrations more rapidly than subcutaneous or deltoid injection 1
- There are no absolute contraindications to epinephrine in anaphylaxis, including cardiac disease, advanced age, or frailty 1, 2
- Epinephrine autoinjectors should be used if available to minimize dosing errors when staff experience is limited 1
Immediate Concurrent Actions
While preparing or immediately after epinephrine:
- Activate emergency medical services (call 911) 1
- Position patient supine with legs elevated (if tolerated and no respiratory distress) 1
- Administer supplemental oxygen at 6-8 L/min 1, 2
- Establish IV access and give rapid crystalloid bolus: 500-1000 mL in adults, 10-20 mL/kg in children 1, 2
Secondary Adjunctive Treatments (After Epinephrine)
These should never be given before or instead of epinephrine:
For bronchospasm:
- Inhaled albuterol (2.5-5 mg nebulized) for persistent lower respiratory symptoms after epinephrine 1, 2
Antihistamines (limited role):
- H1 antihistamine: Diphenhydramine 25-50 mg IV (1-2 mg/kg in children, max 50 mg) 1
- H2 antihistamine: Ranitidine 50 mg IV over 5 minutes (1 mg/kg in children, diluted in 20 mL) 1, 2
- Note: The combination of H1 + H2 is superior to H1 alone, but these only address cutaneous manifestations and have no role in life-threatening symptoms 1, 2
Glucocorticoids:
- Do NOT administer glucocorticoids for acute anaphylaxis treatment due to slow onset of action (hours) 1, 2
- Do NOT give glucocorticoids to prevent biphasic reactions—multiple systematic reviews show no clear evidence of benefit 1, 2
Repeat Dosing Algorithm
If symptoms persist or progress after initial epinephrine dose:
- Repeat intramuscular epinephrine every 5-15 minutes as needed 1
- Approximately 7-18% of patients require >1 dose of epinephrine 1
- If no response after 2-3 IM doses and patient remains hypotensive, consider IV epinephrine infusion (1:10,000 concentration, NOT 1:1000) in a monitored setting 1, 2
Post-Treatment Observation
All patients must be observed in a monitored setting capable of managing anaphylaxis until symptoms fully resolve: 1
- Minimum 4-6 hours observation for most patients 1, 2
- Extended observation (6-24 hours) or hospital admission for severe reactions requiring >1 dose of epinephrine, as these patients have 4.8-fold increased risk of biphasic anaphylaxis 1
- Biphasic reactions occur in 7-10% of cases, with mean onset at 11 hours (range up to 72 hours) 1
Critical Pitfalls to Avoid
- Delaying epinephrine administration is the leading cause of anaphylaxis fatalities—approximately 500-1000 deaths occur annually in the US, most from delayed epinephrine 1, 2
- Never use antihistamines or glucocorticoids as first-line or sole treatment—this significantly increases mortality risk 1, 2, 4
- Never administer IV epinephrine outside monitored settings or use 1:1000 concentration IV (must use 1:10,000 for IV route) 1, 2
- Do not give epinephrine subcutaneously or in the deltoid—absorption is significantly slower than IM thigh injection 1
Discharge Requirements
Before discharge, ensure patient receives: